TCL Archive Six More Clinical Trials Proposed For High Priority Status, But Per Case Funds For Them Not Assured June 16, 1989
TCL Archive AACR President Coffey Urges Clinton to Support Doubling of NIH, NCI Budgets December 19, 1997
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
